Homology Medicines: Q2 Earnings Snapshot
In this article:
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Homology Medicines Inc. (FIXX) on Monday reported a loss of $35 million in its second quarter.
On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 61 cents.
The gene editing company posted revenue of $354,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX
